One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The relation between excess adiposity and breast cancer in women: Clinical implications and management
Maria D. Hurtado a b 1, Elif Tama a b, Stacey D’Andre c, Chrisandra L. Shufelt d
doi : 10.1016/j.critrevonc.2023.104213
Volume 193, January 2024, 104213
Natriuretic peptides: Another tool for the management of cancer?
Jorge Balaguer a, Jesús GarcÃa-Foncillas b c, José Tuñón a c d e
doi : 10.1016/j.critrevonc.2023.104219
Volume 193, January 2024, 104219
Adavosertib and beyond: Biomarkers, drug combination and toxicity of WEE1 inhibitors
Chi Zhang a b 1, Ke Peng a b 2, Qing Liu a b 3, Qihong Huang a c 4, Tianshu Liu a b 5
doi : 10.1016/j.critrevonc.2023.104233
Volume 193, January 2024, 104233
Advances, opportunities and challenges in developing therapeutic cancer vaccines
Zhihui Duan, Dandan Yang, Ping Yuan, Xiaoming Dai, Guodong Chen, Daichao Wu
doi : 10.1016/j.critrevonc.2023.104198
Volume 193, January 2024, 104198
Antibody drug conjugates in older patients: State of the art
Layal Rached a, Arthur Geraud b, Maxime Frelaut b, Zoe AP Thomas b, Vincent Goldschmidt a, Geoffroy Beraud-Chaulet b, Celine Nagera-Lazarovici b, Francois-Xavier Danlos a, Clemence Henon a, Claudia Parisi a, Anas Gazzah a, Rastilav Bahleda a, Sophie Postel Vinay a, Cristina Smolenschi a, Antoine Hollebecque a, Jean-Marie Michot a, Vincent Ribrag a, Yohann Loriot a, Stephane Champiat a, Kaissa Ouali a…Capucine Baldini a
doi : 10.1016/j.critrevonc.2023.104212
Volume 193, January 2024, 104212
Recent approaches for the treatment of uveal melanoma: Opportunities and challenges
Sauban Ahmed Khan a, Waleed H. Almalki b, Swaranjeet Arora c, Prashant Kesharwani a 1
doi : 10.1016/j.critrevonc.2023.104218
Volume 193, January 2024, 104218
Potential applications of ferroptosis inducers and regulatory molecules in hematological malignancy therapy
Xiao Tang a, Yujie Niu a, Jinli Jian a, Yuancheng Guo a, Yin Wang a, Yu Zhu a, Bei Liu a b
doi : 10.1016/j.critrevonc.2023.104203
Volume 193, January 2024, 104203
Cost-effectiveness of first-line immunotherapy for advanced non-small cell lung cancer with different PD-L1 expression levels: A comprehensive overview
Changjin Wu a, Wentan Li a, Hongyu Tao b, Xiyan Zhang a, Yu Xin c, Ruomeng Song a, Kaige Wang d, Ling Zuo e f, Yuanyi Cai a, Huazhang Wu a, Wen Hui c
doi : 10.1016/j.critrevonc.2023.104195
Volume 193, January 2024, 104195
cGAS-STING at the crossroads in cancer therapy
Rui Wang a b, Aashiq Hussain c, Quanquan Guo a b, Meimei Ma d
doi : 10.1016/j.critrevonc.2023.104194
Volume 193, January 2024, 104194
Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies
Ali Zarezadeh Mehrabadi a b, Faezeh Shahba a b, Hossein Khorramdelazad c, Nazanin Aghamohammadi a b, Milad Karimi a b, Kowsar Bagherzadeh d, Majid Khoshmirsafa a b, Ramin Massoumi e 1, Reza Falak a b
doi : 10.1016/j.critrevonc.2023.104200
Volume 193, January 2024, 104200
Benefits and risks of PD-1/PD-L1 inhibitors for recurrent small cell lung cancer: A systematic review and meta-analysis
Juyue Zhou a 1, Zhonghai Du b 2, Yan Liang b 2, Sensen Zhang b 2
doi : 10.1016/j.critrevonc.2023.104222
Volume 193, January 2024, 104222
Natural killer cells at the forefront of cancer immunotherapy with immune potency, genetic engineering, and nanotechnology
Weiyi Pan a b 1, Tao Tao c 1, Yishu Qiu d, Xiao Zhu e, Xiaorong Zhou a
doi : 10.1016/j.critrevonc.2023.104231
Volume 193, January 2024, 104231
Immune checkpoint inhibitors therapy as the game-changing approach for pediatric lymphoma: A brief landscape
Sara Ebrahimi a b, Adrina Habibzadeh b c, Soroush Khojasteh-Kaffash b d, Parya Valizadeh b e, Noosha Samieefar b f, Nima Rezaei b g h
doi : 10.1016/j.critrevonc.2023.104225
Volume 193, January 2024, 104225
CpG-biomarkers in tumor tissue and prediction models for the survival of colorectal cancer: A systematic review and external validation study
Tanwei Yuan a b, Dominic Edelmann c, Jakob N. Kather d e, Ziwen Fan a, Katrin E. Tagscherer f g, Wilfried Roth f g, Melanie Bewerunge-Hudler h, Alexander Brobeil i, Matthias Kloor j, Hendrik Bläker k, Barbara Burwinkel l m, Hermann Brenner a n o, Michael Hoffmeister a
doi : 10.1016/j.critrevonc.2023.104199
Volume 193, January 2024, 104199
Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: Practical indications from an Italian multidisciplinary group
Umberto Malapelle a, Alessandro Delle Donne b, Fabio Pagni c 1, Filippo Fraggetta d 1, Elena Guerini Rocco e f 1, Giulia Pasello g 1, Giuseppe Perrone h i 1, Francesco Pepe a, Simona Vatrano d, Sandro Pignata j, Carmine Pinto k, Giancarlo Pruneri l 1, Antonio Russo m, Hector J. Soto Parra n, Stefania Vallone o, Antonio Marchetti p 1, Giancarlo Troncone a 1 2, Silvia Novello q 2
doi : 10.1016/j.critrevonc.2023.104217
Volume 193, January 2024, 104217
Preoperative therapy in melanoma: Evolving perspectives in clinical trials
doi : 10.1016/j.critrevonc.2023.104193
Volume 193, January 2024, 104193
Primary neuroendocrine neoplasms of the vulva: A review of the MITO rare cancer group
Amelia Barcellini a b, Tullio Golia D’Augè c, Vincenzo Dario Mandato d, Ilaria Cuccu c, Angela Musella c, Robert Fruscio e, Maria Giuseppa Vitale f, Ruby Martinello g, Giorgia Mangili h, Sandro Pignata i, Innocenza Palaia c
doi : 10.1016/j.critrevonc.2023.104201
Volume 193, January 2024, 104201
Tumor budding is a prognostic factor in head and neck squamous cell carcinoma: A comprehensive meta-analysis and trial sequential analysis
Fábio França Vieira e Silva a b 1, Vito Carlo Alberto Caponio c 1, Mario Pérez-Sayáns a b, MarÃa Elena PadÃn-Iruegas b d, Marco Mascitti e, Cintia Micaela Chamorro-Petronacci a b, José Manuel Suaréz-Peñaranda a b, Alejandro Ismael Lorenzo-Pouso a
doi : 10.1016/j.critrevonc.2023.104202
Volume 193, January 2024, 104202
Treatment of acral and mucosal melanoma: Current and emerging targeted therapies
Jiaran Zhang 1, Huichun Tian 1, Lili Mao, Lu Si
doi : 10.1016/j.critrevonc.2023.104221
Volume 193, January 2024, 104221
Somatostatin receptor2 (SSTR2) expression, prognostic implications, modifications and potential therapeutic strategies associates with head and neck squamous cell carcinomas
Songqing Fan a c, Hongmei Zheng a c, Yuting Zhan a c, Jiadi Luo a c, Hongjing Zang a c, Huilin Wang a c, Weiyuan Wang b, Yue Xu. a c
doi : 10.1016/j.critrevonc.2023.104223
Volume 193, January 2024, 104223
Toxic warhead-armed antibody for targeted treatment of glioblastoma
Jingjing Xi, Kai Liu, Zhaolei Peng, Xiaolin Dai, Yulin Wang, Chunyan Cai, Dejun Yang, Chunmei Yan, Xiaofang Li 1
doi : 10.1016/j.critrevonc.2023.104205
Volume 193, January 2024, 104205
Cancer-associated fibroblasts in neoadjuvant setting for solid cancers
Yanan Gu a b 1, Qiangda Chen c d 1, Hanlin Yin c d, Mengsu Zeng a, Shanshan Gao a 2, Xiaolin Wang a b 2
doi : 10.1016/j.critrevonc.2023.104226
Volume 193, January 2024, 104226
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints
Daniele Fanale a 1, Lidia Rita Corsini a 1, Marco Bono a 1, Ugo Randazzo a 1, Nadia Barraco a, Chiara Brando a, Daniela Cancelliere a, Silvia Contino a, Ambra Giurintano a, Luigi Magrin a, Erika Pedone a, Alessandro Perez a, Paola Piraino a, Alessia Pivetti a, Emilia Di Giovanni a, Tancredi Didier Bazan Russo a, Ornella Prestifilippo a, Vincenzo Gennusa a, Gianni Pantuso b, Antonio Russo a 2…Viviana Bazan c 2
doi : 10.1016/j.critrevonc.2023.104220
Volume 193, January 2024, 104220
Comparative efficacy and tolerability of first-line treatments for untreated, HER2-negative, advanced gastric cancer: systematic review and network meta-analysis
Tongze Cai a, Liuguan Liang b, Xingxing Zhao b, Caiyue Lin b, Dandan Li b, Jinghui Zheng b
doi : 10.1016/j.critrevonc.2023.104216
Volume 193, January 2024, 104216
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis
Nicoletta Staropoli a b, Domenico Ciliberto b, Francesco Luciano a, Cristina Napoli a, Martina Costa a, Giacomo Rossini a, Mariamena Arbitrio c, Caterina Labanca a, Caterina Riillo a, Teresa Del Giudice d, Antonella Crispino a, Angela Salvino b, Antonio Galvano e, Antonio Russo e f, Pierfrancesco Tassone a b f, Pierosandro Tagliaferri a b
doi : 10.1016/j.critrevonc.2023.104229
Volume 193, January 2024, 104229
